
Fortis Healthcare Q1 Results FY27: Uniresearch Prediction and Analysis
Fortis Healthcare Q1 Results FY27: Uniresearch projects Revenue Rs 2,526 Cr | PAT Rs 400 Cr (Uniresearch trailing analysis). Q4 FY26: Rev Rs 2,365 Cr | PAT Rs 271 Cr.
Updated: 25 Jun 2026 • 12:18 pm
Posted by:

Fortis Healthcare Q1 Results FY27 outlook from Uniresearch is anchored on verified Q4 FY26 actuals and Uniresearch trailing analysis. Uniresearch projects Fortis Healthcare Q1 FY27 Revenue Rs 2,526 Cr (+16.6% YoY) and PAT Rs 400 Cr (+50.0% YoY). Prepared by Ankit Jaiswal.
Click Here – Get Free Investment Predictions
Fortis Healthcare Q1 Results FY27 – Uniresearch Prediction
| Metric | Q1 FY26 Actual | Q1 FY27 Uniresearch Prediction | YoY Change | Source |
|---|---|---|---|---|
| Fortis Healthcare Revenue (Rs Cr) | 2,167 | 2,526 | +16.6% | Uniresearch | Uniresearch trailing analysis |
| PAT (Rs Cr) | 267 | 400 | +50.0% | Uniresearch | Uniresearch trailing analysis |
| Avg Analyst Target | See screener | 12-month view | – | Uniresearch trailing analysis |
Fortis Healthcare Q4 FY26 Performance
| Metric | Q4 FY26 Actual | vs Q1 FY26 | Source |
|---|---|---|---|
| Revenue (Rs Cr) | 2,365 | +9.1% | Screener consolidated |
| PAT (Rs Cr) | 271 | +1.5% | Screener consolidated |
Analyst Views and Growth Outlook
The Uniresearch trailing analysis projects Fortis Healthcare FY27 revenue at +16.6% and profit at +50.0% YoY. Uniresearch applied these growth rates to Q1 FY26 actuals to derive the Q1 FY27 prediction. Q4 FY26 actuals showed Fortis Healthcare delivering revenue of Rs 2,365 Cr and PAT of Rs 271 Cr.
Key Watchpoints
Revenue Delivery
Key question: can Fortis Healthcare reach Rs 2,526 Cr in Q1 FY27 revenue, representing +16.6% YoY growth over the Q1 FY26 base of Rs 2,167 Cr.
PAT vs Growth Target
Profit performance of Rs 400 Cr (+50.0%) vs the Q1 FY26 base of Rs 267 Cr is the profitability watchpoint for Fortis Healthcare in Q1 FY27.
Risks
Revenue Shortfall
Revenue below the +16.6% consensus would indicate sector headwinds or execution delays for Fortis Healthcare.
Margin Pressure
Cost increases or margin compression could challenge the +50.0% PAT growth projection for Fortis Healthcare in Q1 FY27.
Conclusion
The Fortis Healthcare Q1 FY27 Uniresearch projection of Revenue Rs 2,526 Cr and PAT Rs 400 Cr is derived from the Uniresearch trailing analysis. Investors should watch Q4 FY26 actuals as the base, and track Fortis Healthcare live on the Univest Screener.
Track Fortis Healthcare Live on the Univest Screener
Download the Univest iOS App or Univest Android App for live FY27 alerts.
Disclaimer: Revenue and PAT actuals are sourced from consolidated quarterly financial data. Q1 Results FY27 Uniresearch predictions are derived by applying analyst consensus growth rates to verified Q1 FY26 actuals. These are projections, not guaranteed outcomes. Investments in securities are subject to market risk. For educational purposes only. SEBI RA INH000013776.
FAQs on Fortis Healthcare Q1 Results FY27
What is Uniresearch’s PAT prediction for Fortis Healthcare Q1 Results FY27?
Ans. Uniresearch projects Fortis Healthcare Q1 FY27 PAT at Rs 400 Cr (+50.0% vs Q1 FY26 base Rs 267 Cr).
What is the Revenue forecast for Fortis Healthcare Q1 Results FY27?
Ans. Fortis Healthcare Q1 FY27 Revenue is projected at Rs 2,526 Cr (+16.6% consensus).
What were Fortis Healthcare Q4 FY26 actuals for Fortis Healthcare Q1 Results FY27?
Ans. Q4 FY26 Revenue Rs 2,365 Cr and PAT Rs 271 Cr.
How many analysts cover Fortis Healthcare Q1 Results FY27?
Ans. The prediction uses Uniresearch trailing analysis, avg target Rs 0.
What consensus applies to Fortis Healthcare Q1 Results FY27?
Ans. Revenue +16.6% and profit +50.0% (Uniresearch trailing analysis).
What are the main risks to Fortis Healthcare Q1 Results FY27?
Ans. Revenue missing +16.6% consensus and PAT pressure vs +50.0% growth target.
What is the Q1 FY26 base for Fortis Healthcare Q1 Results FY27?
Ans. Q1 FY26 Revenue Rs 2,167 Cr and PAT Rs 267 Cr.
Recent Articles

HCL Technologies Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
25 June 2026

Hindustan Unilever Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
25 June 2026

ICICI Bank Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
25 June 2026

National Aluminium Company Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
25 June 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
HCL Technologies Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
Hindustan Unilever Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
ICICI Bank Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
National Aluminium Company Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
Popular this week
HCL Technologies Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
Hindustan Unilever Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
ICICI Bank Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints
National Aluminium Company Q1 Results FY27: Uniresearch Predictions, Analyst Views and Key Watchpoints

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





